Replies to post #9510 on Aurinia Pharmaceuticals Inc (AUPH)

[zzaatt]

but ph 3 results are a relative easy hurdle jump over compared to the approval process over the next 6-9 months.

BS!!!

The "idiosyncrasies" of the FDA will not keep a desperately needed drug off the market if the P3 results are good. The real question over the following months is the question of who will buy the company, for how much, and who's going to carry forward the dry eye indication.

[CoolG73]

Ok, just so that no one misunderstands me here, I am still bullish on P3 and still believe that they will meet their primary endpoint, i am just not convinced that they will beat P2 numbers for the reasons I mentioned in my previous 2 posts. The claim by management in their CC that delta of over 10% is clinically statistical is the main reason I am bullish. I repeat, we dont need to beat P2 numbers , we just need to meet primary endpoint and according to management we just need a bit over 10% to do it